Smita Bhatia
Children's Oncology Group · University of Alabama at Birmingham · City of Hope Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Smita Bhatia as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:26 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06639958 · A Study of Different Programs to Help ALL Patients With Taking Maintenance Medicine at HomeChildren's Oncology Group · suspended · Acute Lymphoblastic Leukemia, Childhood Acute Lymphoblastic Leukemia · principal investigator
- Ph3NCT01503632 · Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First RemissionChildren's Oncology Group · completed · Acute Lymphoblastic Leukemia · principal investigator
- Ph2NCT01196936 · Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer SurvivorsUniversity of Alabama at Birmingham · active not recruiting · Breast Cancer · principal investigator
- N/ANCT00736749 · Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group StudiesChildren's Oncology Group · recruiting · Hematopoietic Cell Transplantation Recipient, Leukemia, Solid Tumor · principal investigator
- N/ANCT00268528 · Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in RemissionChildren's Oncology Group · completed · Childhood Acute Lymphoblastic Leukemia in Remission · principal investigator
- N/ANCT00082745 · Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer SurvivorsChildren's Oncology Group · completed · Childhood Malignant Neoplasm · principal investigator
- N/ANCT00005881 · Quality of Life in Children Treated for CancerChildren's Oncology Group · completed · Leukemia, Lymphoma, Unspecified Childhood Solid Tumor, Protocol Specific · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:26 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Mitigating Long-term Treatment-related Morbidity in Childhood Cancer SurvivorsR35CA220502 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · fiscal years 2018 to 2024 · $808,678 awarded in 2024Same name and institution; not confirmed by an ID
- BMT Survivor Study-2 (BMTSS-2)U01CA213140 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · fiscal years 2019 to 2023 · $1,266,852 awarded in 2023Same name and institution; not confirmed by an ID
- Therapy-related leukemia following autologous transplantation for lymphomaP50CA107399 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · fiscal years 2018 to 2022 · $409,866 awarded in 2022Same name and institution; not confirmed by an ID
- Comprehensive Approach to Improve Medicine Adherence in Pediatric LeukmiaR01CA174683 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · fiscal years 2014 to 2018 · $597,219 awarded in 2018Grant number is on one of their registry trials
- Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Breast Cancer Risk ReductionR01CA140245 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · fiscal years 2014 · $348,987 awarded in 2014Grant number is on one of their registry trials
- Role of Genetic Susceptibility in Therapy-related Subsequent MalignanciesR01CA139633 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · fiscal years 2010 to 2014 · $470,514 awarded in 2014Same name and institution; not confirmed by an ID
- Hematopoietic Cell Transplant - Long-term Follow-Up CoreP01CA030206 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · fiscal years 2006 to 2010 · $216,006 awarded in 2010Same name and institution; not confirmed by an ID
- Ethnic Differences in Survival after Childhood ALLR01CA096670 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · fiscal years 2004 to 2009 · $166,000 awarded in 2009Grant number is on one of their registry trials
- BONE MARROW TRANSPLANT (BMT) SURVIVORS STUDYR01CA078938 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · fiscal years 2000 to 2003 · $436,039 awarded in 2003Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Children's Oncology Group NCI Community Oncology Research Program (NCORP) Research Base GrantUG1CA189955 · NCI · COG RESEARCH FOUNDATION, LLC · PI BRAD H POLLOCK, Michael E. Roth · fiscal years 2014 to 2026
- Community Clinical Oncology Program Research BaseU10CA095861 · NCI · CHILDREN'S HOSP OF PHILADELPHIA · PI BRAD H POLLOCK · fiscal years 2002 to 2013
- COG NCTN Network Group Operations CenterU10CA180886 · NCI · COG RESEARCH FOUNDATION, LLC · PI Douglas S. Hawkins · fiscal years 2014 to 2026Named on NCT00736749, NCT00082745
- Children's Oncology Group Chair's GrantU10CA098543 · NCI · CHILDREN'S HOSP OF PHILADELPHIA · PI PETER C. ADAMSON · fiscal years 2003 to 2013Named on NCT00736749
- Nemours NCI Community Oncology Research Program (NCORP)UG1CA189958 · NCI · NEMOURS CHILDREN'S HOSPITAL, DELAWARE · PI Emi H Caywood · fiscal years 2014 to 2026Named on NCT00736749, NCT00082745
Most cited trial papers
Clinical-trial papers with this author name in childhood acute lymphoblastic leukemia, ranked by citations from NIH iCite, fetched 2026-11-12 11:26 UTC. The ranking covers the 200 most relevant of 9 PubMed records, and a shared surname and initials can bring in a namesake. All 9 on PubMed
- Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia.J Clin Oncol · 2015354 citationsRCR 12.0
- 179 citationsRCR 5.7
- Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983.Blood · 2002141 citationsRCR 3.1
- Late Mortality After Dexrazoxane Treatment: A Report From the Children's Oncology Group.J Clin Oncol · 201573 citationsRCR 2.2
- Late health outcomes after dexrazoxane treatment: A report from the Children's Oncology Group.Cancer · 202247 citationsRCR 3.6
- 39 citationsRCR 1.6
- Effect of a Daily Text Messaging and Directly Supervised Therapy Intervention on Oral Mercaptopurine Adherence in Children With Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.JAMA Netw Open · 202030 citationsRCR 1.9
- Causes of Inferior Outcome in Adolescents and Young Adults with Acute Lymphoblastic Leukemia: Across Oncology Services and Regardless of Clinical Trial Enrollment.Cancer Epidemiol Biomarkers Prev · 201827 citationsRCR 1.1
- Comprehensive characterization of pharmacogenetic variants in TPMT and NUDT15 in children with acute lymphoblastic leukemia.Pharmacogenet Genomics · 202217 citationsRCR 1.2